Quick Answer
Phio Pharmaceuticals Corp. reported Total Assets of $21.49 million for the year ending 2025.
- Phio Pharmaceuticals Corp. showed an increase of +274.5% in Total Assets from 2024 to 2025.
- This data is from Phio Pharmaceuticals Corp.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $1.33 million | Q2 2012: $8.02 million | Q3 2012: $6.71 million | Q1 2013: $19.97 million | Q2 2013: $18.00 million | Q3 2013: $16.21 million | Q1 2014: $12.46 million | Q2 2014: $12.55 million | Q3 2014: $10.90 million | Q1 2015: $7.17 million | Q2 2015: $14.95 million | Q3 2015: $12.70 million | Q1 2016: $8.17 million | Q2 2016: $6.52 million | Q3 2016: $4.90 million | Q1 2017: $10.51 million | Q2 2017: $8.39 million | Q3 2017: $6.03 million | Q1 2018: $3.09 million | Q2 2018: $6.03 million | Q3 2018: $3.81 million | Q1 2019: $13.68 million | Q2 2019: $12.11 million | Q3 2019: $10.08 million | Q1 2020: $14.31 million | Q2 2020: $20.21 million | Q3 2020: $18.24 million | Q1 2021: $33.86 million | Q2 2021: $31.66 million | Q3 2021: $27.94 million | Q1 2022: $22.16 million | Q2 2022: $20.14 million | Q3 2022: $15.79 million | Q1 2023: $9.71 million | Q2 2023: $12.30 million | Q3 2023: $9.54 million | Q1 2024: $6.85 million | Q2 2024: $5.30 million | Q3 2024: $5.87 million | Q1 2025: $13.44 million | Q2 2025: $11.30 million | Q3 2025: $11.51 million.
- Over the full 15 years of available data (2011 to 2025), Phio Pharmaceuticals Corp.'s Total Assets has grown by 1,168.4%.
- Historical annual values: Fiscal year 2025: $21.49 million | Fiscal year 2024: $5.74 million | Fiscal year 2023: $9.36 million | Fiscal year 2022: $12.81 million | Fiscal year 2021: $25.17 million | Fiscal year 2020: $15.74 million | Fiscal year 2019: $8.04 million | Fiscal year 2018: $15.32 million | Fiscal year 2017: $4.10 million | Fiscal year 2016: $13.40 million | Fiscal year 2015: $11.16 million | Fiscal year 2014: $9.19 million | Fiscal year 2013: $14.94 million | Fiscal year 2012: $5.59 million | Fiscal year 2011: $1.69 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: